To determine whether ILC2s are sufficient to transfer protection during CDI, we adoptively transferred ILC2s from the mesenteric lymph nodes and colon of IL-33-treated mice and ex vivo expanded them in the presence of IL-33, IL-2 and IL-7 as described previously40,41. This evidence concerns the gene IL33 and clostridium difficile infection.